Related Experiment Videos
Modifying TNFalpha for therapeutic use: a perspective on the TNF receptor system
A Hasegawa1, W Takasaki, M I Greene
1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
Mini Reviews in Medicinal Chemistry
|October 9, 2002
Summary
Small molecule antagonists targeting tumor necrosis factor-alpha (TNFalpha) were developed for autoimmune diseases. These novel TNFalpha inhibitors mimic soluble TNF receptors, offering a new therapeutic avenue.
Area of Science:
- Immunology and Molecular Biology
- Drug Discovery and Development
Background:
- Tumor necrosis factor-alpha (TNFalpha) is a key inflammatory mediator implicated in various autoimmune diseases.
- Current macromolecular inhibitors of TNFalpha show therapeutic promise, but development of small molecule alternatives is ongoing.
Purpose of the Study:
- To review the development of novel small molecule TNFalpha antagonists.
- To present the current status of these small molecule anti-TNFalpha mimetics and related agents.
Main Methods:
- Structure-based drug design utilizing the crystal structure of the TNF receptor complex.
- Characterization of small molecule antagonists for specificity and biological function.
Main Results:
- Successful development of specific small molecule TNFalpha antagonists.
- Demonstration that these antagonists mediate biological functions comparable to inhibitory soluble TNF receptors.
Conclusions:
- Small molecule TNFalpha mimetics represent a promising therapeutic strategy for autoimmune diseases.
- The development of these agents warrants further investigation and clinical evaluation.